May 14, 2026 — Kairos Pharma (NYSE American: KAPA) announced it has been named a winner in the 2026 GHP Magazine Healthcare & Pharmaceutical Awards, receiving recognition as the USA leader in drug resistance development. The award highlights the company’s work in advancing cancer therapeutics designed to address treatment resistance, underscoring Kairos’ focus on extending the effectiveness of existing cancer therapies through innovative drug resistance-targeting approaches.
May 14, 2026 — BOXABL and FG Merger II Corp. (NASDAQ: FGMC) announced that the U.
May 14, 2026 — Tonix Pharmaceuticals (NASDAQ: TNXP) announced a poster presentation at ISPOR 2026 highlighting findings from a retrospective cohort study analyzing U. S.
May 14, 2026 — This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.
May 14, 2026 — This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising.
May 14, 2026 — HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U. S.
May 14, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
May 14, 2026 — American Fusion(TM), developer of next-generation fusion energy technologies, has completed the structural frame for its 5MW Texatron(TM) pre-production system, marking a transition toward integrated assembly and controlled testing. The company is developing modular fusion energy systems through its subsidiary Kepler Fusion Technologies, with a focus on scalable infrastructure-grade applications.
May 13, 2026 — The cannabis industry has spent years debating what the eventual rollback of Section 280E could mean for businesses operating legally under state law. Tax professionals have largely agreed on one point: if marijuana is moved to a lower federal drug classification, any tax relief would likely apply only going forward.
May 13, 2026 — Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.
May 13, 2026 — Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.
May 13, 2026 — Forward Industries (NASDAQ: FWDI), focused on building and managing a large-scale Solana (SOL) treasury, recently appointed Mark Brazier as its new CFO. “In his role as CFO, Brazier will oversee Forward’s financial operations, capital structure, financial reporting, capital markets activities, and more, as Forward Industries continues to operate and grow as the worlds-largest publicly traded Solana treasury company,” reads a recent article.
May 13, 2026 — Wearable Devices (NASDAQ: WLDS) announced the launch of Mudra Pro, a next-generation wearable neural sensing platform designed for developers, researchers, enterprise innovation teams and technology partners building AI, XR and human-machine interaction applications. The wrist-worn platform combines synchronized electromyography, photoplethysmography and inertial measurement sensors with embedded processing, sensor fusion and low-latency Bluetooth communication to support physiological state estimation, intent decoding, behavioral analytics and rapid prototyping, with the company positioning the product as a key outcome of its ai6 Labs initiative focused on AI-native wearable computing and next-generation human-computer interaction.
May 13, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
May 13, 2026 — Oncotelic Therapeutics (OTCQB: OTLC), alongside Sapu Nano, announced that the first patient has been dosed in the Phase 1b clinical trial evaluating Sapu003, an investigational intravenous Deciparticle(TM) formulation of everolimus for patients with advanced mTOR-sensitive solid tumors. The open-label, dose-escalation study is designed to assess safety, tolerability, pharmacokinetics and preliminary anti-tumor activity across patient cohorts including HR-positive/HER2-negative breast cancer and multiple additional tumor types, with Sapu003 developed as a weekly IV formulation intended to address limitations associated with oral everolimus delivery, including variable absorption and dose-limiting toxicity.
May 13, 2026 — Greenland’s recent agreements secures access to advanced rig capacity, operational support intended to facilitate future drilling activity. Greenland now possess the best-in-class logistics and operational infrastructure, among the largest challenges facing Arctic exploration.
May 13, 2026 — This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.
May 13, 2026 — As the U. S.
May 13, 2026 — BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved.
May 13, 2026 — BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (“T2DM”) rank among the most urgent and costly healthcare problems facing the world today, contributing to surging rates of cardiovascular disease, fatty liver disease, kidney complications and ballooning healthcare expenses. What once represented a specialized class of diabetes treatments has grown into one of the most consequential therapeutic categories in modern medicine, with GLP-1 receptor agonists now fundamentally restructuring how obesity, metabolic disease and potentially even neurodegeneration are treated.
